Clinical Trial: Development of key technologies for the early warning of cardiorenal metabolic syndrome based on multimodal imaging, genomics, and metabolomics (China)

Posted On: 2026-08-31

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development of key technologies for the early warning of cardiorenal metabolic syndrome based on multimodal imaging, genomics, and metabolomics'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131151

Registration Time: 2026/08/28

Type: Observational study

Primary Sponsor: Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=315921

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Development of key technologies for the early warning of cardiorenal metabolic syndrome based on multimodal imaging, genomics, and metabolomics (China)